Cannabis Global (OTC: CBGL), a cannabinoid and hemp extract science-forward company developing infusion and delivery technologies, today provided shareholders with more details following the company’s recent 18.8% strategic investment stake in Natural Plant Extract (“NPE”). Operating out of Lynwood, California, NPE holds a Type 7 California manufacturing and distribution license, allowing for cannabis product distribution anywhere in the state. Through the newly formed strategic relationship, Cannabis Global and NPE management teams are already collaborating on multiple levels, including the integration of several of the company’s technologies in products manufactured by NPE and distributed by NPE’s Northern Lights Distribution. “Aside from the direct positive balance sheet impact, which we will outline in our upcoming fiscal year-end filing with the SEC, we acquired the stake in NPE for the strategic importance to our future business,” said Cannabis Global CEO Arman Tabatabaei in the press release. “There are multiple synergies between our internally developed technologies and the cannabis market sectors targeted by NPE and its business partners. We believe the recent acquisition and the growing relationship between the management teams will create opportunities to lower our manufacturing costs, provide important distribution channels for our unique product lines, and offer our company multiple licensing opportunities.”

To view the full press release, visit https://cnw.fm/ImgZd

About Cannabis Global Inc.

Cannabis Global, formerly known as MCTC Holdings Inc., is a fully audited and reporting company with the U.S. Securities & Exchange Commission, trading with the stock symbol CBGL. The company is an emerging force in cannabinoid sciences and highly bioavailable hemp and cannabis infusion technologies. Cannabis Global has an actively growing portfolio of cannabis investments and intellectual property, having filed six provisional patents relative to the areas of cannabinoid delivery systems and cannabinoid polymeric nanoparticles. The company markets its consumer products under the Hemp You Can Feel(TM) brand name. Cannabis Global launched its Project Varin early in 2020 to develop new delivery methods for rare cannabinoid tetrahydrocannabivarin (THV-C) and develop products based on this and other rare cannabinoids. For more information, visit the company’s website at www.CannabisGlobalInc.com.

NOTE TO INVESTORS: The latest news and updates relating to CBGL are available in the company’s newsroom at http://cnw.fm/CBGL

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Cannabis Global (OTC: CBGL), a cannabinoid and hemp-extract, science-forward company developing infusion and delivery technologies, is introducing the industry’s first no-taste, nonclouding, chemical-free hemp product line. CBGL’s revolutionary Hemp You Can Feel Sweeteners is the first hemp and cannabinoid-rich offering that delivers sweetening for both beverages and food in a cloud-free, 100% water-soluble format. The product contains no  chemicals, additives, or GMOs. Using unique noninfused honey-bee hemp and cannabinoid technologies, the innovative product line fills consumer demand for all-natural options. Cannabis Global will begin shipping Hemp You Can Feel Sweeteners to customers next week. “Just over a year ago, we analyzed the available water-soluble food and beverage hemp infusion technologies and were unimpressed with the options,” CBGL CEO Arman Tabatabaei stated in the press release. “Most clouded beverages tasted simply horrible and the vast majority used unhealthy and unnatural chemicals. With the limited options, we set out to develop something better. We have succeeded well beyond our expectations!”

To view the full press release, visit http://cnw.fm/C1SUA

About Cannabis Global Inc.

Cannabis Global, formerly known as MCTC Holdings Inc., is a fully audited and reporting company with the U.S. Securities & Exchange Commission. The company is an emerging force in the area of cannabinoid sciences and highly bioavailable hemp- and cannabis-infusion technologies. The company does not engage in the production, distribution or sales of any controlled substances, including marijuana. CBGL has an actively growing portfolio of intellectual property, having filed six patents in the areas of cannabinoid delivery systems and cannabinoid polymeric nanoparticles. The company markets its consumer products under the Hemp You Can Feel brand name. Cannabis Global launched its Project Varin early in 2020, designed to develop new delivery methods for rare cannabinoid tetrahydrocannabivarin (THV-C) and to develop products based on this cannabinoid. For more information about the company, visit www.CannabisGlobalInc.com.

NOTE TO INVESTORS: The latest news and updates relating CBGL are available in the company’s newsroom at http://cnw.fm/CBGL

About HempWire

HempWire (HW) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWire (HW) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWire.com

Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.HempWire.com/Disclaimer

Do you have questions or are you interested in working with HW? Ask our Editor

HempWire (HW)
Denver, Colorado
www.HempWire.com
303.498.7722 Office
Editor@HempWire.net

HempWire is part of the InvestorBrandNetwork.

Cannabis Global (OTC: CBGL), a cannabis, cannabinoid and hemp extract science-forward company developing unique infusion technologies and products, today provided a recap of the recently closed fiscal year (Aug. 31). The company also offered insight on its next steps as it begins marketing activities. “It’s been approximately one year since we reorganized the company toward cannabinoid technologies and products,” CBGL CEO Arman Tabatabaei said in the news release. “We have made substantial progress in our selected technology areas, and based on these innovations, we have designed a revolutionary set of products, which are now rolling out into the marketplace. I am pleased to offer our investors and the industry the following summary of activities and insight into our direction for this new fiscal year.”

To view the full press release, visit http://cnw.fm/jAZ8T

About Cannabis Global Inc.

Cannabis Global, formerly known as MCTC Holdings Inc., is a fully audited and reporting company with the U.S. Securities & Exchange Commission, trading with the stock symbol CBGL. The company is an emerging force in the area of cannabinoid sciences and highly bioavailable hemp and cannabis infusion technologies. The company does not engage in the production, distribution or sales of any controlled substances, including marijuana. The company has an actively growing portfolio of intellectual property having filed six patents in the areas of cannabinoid delivery systems and cannabinoid polymeric nanoparticles. The company markets its consumer products under the Hemp You Can Feel brand name. Cannabis Global launched its Project Varin early in 2020 to develop new delivery methods for rare cannabinoid tetrahydrocannabivarin (“THC-V”) and to develop products based on this cannabinoid. For more information, visit the company’s website at www.CannabisGlobalInc.com.

NOTE TO INVESTORS: The latest news and updates relating to CBGL  are available in the company’s newsroom at http://cnw.fm/CBGL

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

The COVID-19 pandemic brought about the closure of many businesses, with industries suffering and economies struggling to recover from the impact of restrictions and lockdowns.

When the pandemic began, marijuana was considered an essential business. Now, with millions in lockdown around the world, many are seeking to grow their portfolio by signing up for classes in the Cannabis Training University (“CTU”).

Jeff Zorn, the CEO of CTU, which is the first and oldest as well as the largest online cannabis college in the world, states that Cannabis Training University has been registering an average of 1,000 new students every month since the beginning of the pandemic, an increase from the 500 student enrollment they were seeing. He adds that most of the students are from Canada and the U.S.

On March16, 2020, it was reported by Statista, which is an online statistics portal, that recreational marijuana sales in California has grown by almost 159%. This was in comparison to March 16, 2019. In Colorado and Washington State, sales had also grown by 46% and 100% respectively by the same date.

Headset, an analytics site that provides market and retail insights to marijuana retailers, stated that marijuana sales in the U.S. had increased rapidly in mid-March, with the growth in sales climaxing at 64%.

With more states moving toward cannabis legalization and the industry growing thus creating demand for skilled employees, it makes sense for people to see the industry as a business opportunity and acquire the necessary skills to learn all they can about the industry as well as the product. It is therefore not a surprise that CTU has recorded a 108% growth in enrollment during this period.

So, what is the CTU?

The Cannabis Training University is headquartered in Denver, Colorado and was established to provide extensive marijuana education to everyone in the world.

The college has trained and certified thousands of students from more than 20 countries across the globe. Their education model allows anyone from anywhere in the world to access their content and educate themselves.

Jeff Zorn, who is a graduate of the school as well, launched CTU in 2009 after leaving corporate medical sales. He stated the reason for this being his traumatic brain injury and how he had used marijuana to recover.

He speculates that with the increase in job loss, many will venture into the marijuana industry.

In addition to teaching, the university also provides staff training for companies in the industry.

However, one should note that as marijuana is still illegal in most states, this makes the college unaccredited. Therefore, one cannot apply for government student loans/grants to help pay for tuition but individuals with marijuana-related convictions can attend these colleges, even though they may find it hard to get a job in the sector because of their record.

While there are no state requirements for those who wish to be employed in this sector, some states ask for state level certifications for role such as bud tending.

To get employment in this sector, managers may prefer applicants that are:

• Knowledgeable
• Versatile
• Flexible
• Patient
• Can persevere
• Have people skills
• Are confident
• Have certification

Furthermore, the college only requires that the individual enrolling is 18 years of age or older.

CTU also provides a certificate as well as the knowledge of an extensive cannabis program for about $1,000. The rates are the same across the globe and students are allowed to learn at their own pace.

Sector players like Cannabis Global Inc. (OTC: CBGL) must be glad that people are looking to the marijuana industry for new sources of employment amid this pandemic.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Cannabis Global (OTC: CBGL), a cannabinoid and hemp-extract, science-forward company developing infusion and delivery technologies, has acquired a stake in Natural Plant Extract of California Inc. (“NPE”). The strategic move places CBGL in a prime position in the multibillion-dollar California cannabis space. The agreement, which closed Aug. 31, 2020, outlined Cannabis Global’s acquisition of 18.8% of NPE’s outstanding capital stock for $2 million. NPE operates a licensed cannabis manufacturing and distribution business operation out of Lynwood, California, and owns a Type 7 California Manufacturing License as well as a California Distribution license. “This is a significant agreement for Cannabis Global, as it provides the company with further penetration into the important California market, which is valued at billions of dollars per year,” said Cannabis Global CEO Arman Tabatabaei in the press release. “We believe we create significant added value for our shareholders and new synergies by combining our managerial talents and technologies with the licenses and marketplace opportunities of NPE. We have aspirations of becoming a major distributor and manufacture of our cannabis products in California. NPE is ahead of most of the competition in the state in terms of permitting, build-out and licensing.”

To view the full press release, visit http://cnw.fm/cTNMJ

About Cannabis Global Inc.

Cannabis Global, formerly known as MCTC Holdings Inc., is a fully audited and reporting company with the U.S. Securities & Exchange Commission. The company is an emerging force in the area of cannabinoid sciences and highly bioavailable hemp- and cannabis-infusion technologies. The company does not engage in the production, distribution or sales of any controlled substances, including marijuana. CBGL has an actively growing portfolio of intellectual property, having filed six patents in the areas of cannabinoid delivery systems and cannabinoid polymeric nanoparticles. The company markets its consumer products under the Hemp You Can Feel brand name. Cannabis Global launched its Project Varin early in 2020, designed to develop new delivery methods for rare cannabinoid tetrahydrocannabivarin (THV-C) and to develop products based on this cannabinoid. For more information about the company, visit www.CannabisGlobalInc.com.

NOTE TO INVESTORS: The latest news and updates relating CBGL are available in the company’s newsroom at http://cnw.fm/CBGL

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

For most people, therapy and or medication helps to cope with anxiety and depression while some prefer meditation and yoga or both methods.

Of late however, treatments for depression and anxiety have been moving towards more natural remedies, particularly CBD oil.

Cannabidiol or CBD is a cannabinoid that exists in the cannabis sativa plant. The cannabinoid is extracted from the plant and refined using various processes, resulting in the cannabidiol. The compound can be purchased in form of CBD gummies if you’d prefer flavor or in a liquid state.

Despite research on the use of CBD oil in treatment of depression and anxiety not being fully definitive as yet, researchers believe the oil alters serotonin signals in your brain through the activation of a receptor. As you know, serotonin is responsible for one’s mood as well as their well-being. CBD thus imitates serotonin through binding and activating your serotonin receptors, which alleviates one’s mood.

We look at CBD oil’s benefits and drawbacks in relation to its use. However, you are encouraged to do more research on your own to ensure you have the right information before using it, especially if you plan on using the oil when traveling.

CBD is all natural and is extracted from the cannabis sativa plant then processed into an oil. This makes it a healthier option as compared to pharmaceutical drugs, making it the better alternative for your body.

People suffering from anxiety and depression commonly experience migraines and cluster headaches. CBD oil relieves this pain and helps treat the root causes of these headaches. In addition to this, CBD oil does this without giving rise to a psychoactive response, addiction or tolerance.

There are various techniques to administer CBD, including mixing into food, using a dropper to place a few drops beneath your tongue, or eating flavored CBD gummies of varying milligram strengths.

Using CBD oil will not get you high as opposed to THC, but it is not approved by the FDA. This means it’s not regulated, therefore there is no standard of quality that has been set that should be adhered to in order for it to qualify as treatment.

Due to the lack of regulations, you may find that some of the products have either higher or lower CBD quantities than what is required. Hence, one should be careful when purchasing this oil as some products that may contain high amounts of THC may be mislabeled, which may result in aggravated anxiety levels, thereby defeating the aim of the treatment.

As its use is fairly new, the oil is not available everywhere. Also, some areas are restricted from using CBD by state and federal laws, so one can only purchase it in states where medical marijuana is legal.

Possible side effects of using CBD oil may include drowsiness, dizziness, nausea, mood swings, loss of appetite, low blood pressure as well as anxiety, making its use as treatment for anxiety, questionable.

While researchers continue to do more studies on the effectiveness of cannabidiol oil as a treatment option for depression and anxiety, the benefits do seem plausible even though the results may not be the same for everyone. So, if you’re looking for natural remedies to help with your anxiety or depression, take your time and look into this. Industry actors like Cannabis Global Inc. (OTC: CBGL) share a lot of helpful information that can guide you on which products are ideal for your condition.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

A federal court of appeal in the U.S. has shot down a request by the Drug Enforcement Administration (“DEA”) challenging a lawsuit against the existing marijuana classification in the federal law. The federal agency was sued by veterans and scientists over their decision to declare cannabis as belonging to schedule 1 of the Controlled Substances Act.

The decision sparked mixed reactions among various players in the marijuana sector who termed the move unconstitutional.

The petitioners in the case argued that the DEA’s scheduling standards misinterpreted the federal law. DEA’s contentious claim dismissing marijuana’s approval for use in medication has set the center stage for protracted legal battles among various actors.

Typically, the government’s stand dismissing the medicinal value of marijuana has disgruntled various marijuana industry players.

The DEA led the government to believe that marijuana hasn’t been proved to be safe for use in the medical sector. In the case, the petitioners argue that a proposal by DEA calling for strict control in the use of marijuana is unconstitutional. The strict rules suggested guiding the use of marijuana continue to elicit a sharp reaction from various marijuana industry advocates.

Delays in licensing more marijuana growers for research purposes has sparked uproar among some lawmakers. A group of disgruntled lawmakers has therefore requested the DEA to fast track the process of formulating policies guiding the issuance of more licenses to research-grade marijuana manufacturers.

On the other hand, medical cannabis patients filed a lawsuit against the DEA petitioning a move by the U.S. government prohibiting the use of marijuana. In the case, medical cannabis patients have requested the U.S. Supreme Court to pick up their case that has undergone several rulings in the lower courts since the initial lawsuit was filed back in 2017.

A number of times, the DEA has been taken to court by Scottsdale Research institute SRI over dubious marijuana policies. The policies are said to hurt the cannabis industry. SRI has been instrumental in pushing for changes in policies governing the marijuana industry, and it is one of the applicants for licenses to manufacture marijuana for research purposes.

Most petitioners in the case have raised concerns about the DEA’s scheduling standards based on government perception that marijuana has no proven medicinal value. In this case, the push and shove in proper policies to guide the cannabis industry has brought a back and forth kind of approach that has delayed the release of appropriate laws and regulations to govern the marijuana sector.

Shane Pennington, one of the legal counsels representing Scottsdale Research Institute SRI indicated that a 9th circuit panel is anticipated to review the arguments of the case and give a decision based on merit.

It is widely expected that the entire cannabis industry, including Cannabis Global Inc. (OTC: CBGL), will be following this case closely until its conclusion.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Recently, the Centers for Disease Control and Prevention (“CDC”) published a notice in the Federal Register asking stakeholders like patients, their families or caregivers as well as health workers to request to participate in conversations about the alternatives to the use of opioids in chronic pain management. These meetings will help to educate the federal government about how marijuana and other alternative treatments can be helpful in managing or treating pain.

In response to the notice, Americans for Safe Access, through its staffer Heather Despres, has written to the CDC requesting to get an individual session during one of those meetings which are expected to last between 45 and 60 minutes.

Americans for Safe Access is a nonprofit which has been advocating for access to medical marijuana since 2002. Despres wants to be selected for one of the 100 planned sessions so that she can talk about pain management from a personal as well as from a professional perspective.

On a personal level, she says she developed chronic pain as a result of pregnancy-related complications as well as from a broken leg she suffered. She reveals that she has been using medical marijuana to deal with this pain on days when it isn’t so intense, then she uses prescription opioids on those days when the pain is severe. Medical marijuana has therefore helped her to use fewer prescription opioids while maintaining a better quality of life.

Professionally, Despres says she interacts with patients on a daily basis and these patients share how marijuana has been instrumental in helping them to manage the pain they suffer from. In some cases, medical marijuana was the only option that could bring any relief.

Heather Despres therefore looks forward to being given an opportunity to share these experiences with the federal officials in the conversations to be hosted. She also calls upon patients, caregivers and other stakeholders to write expressing their interest in sharing their stories with the CDC so that the federal agency can have extensive stakeholder input while formulating policies on how chronic pain can be managed without making the current opioid crisis worse than it already is. Interested parties have until Friday to submit their request for participation in the planned meetings.

This isn’t the first time that the federal agency is seeking public input on pain management. The CDC’s injury prevention and control center previously asked for stakeholder input on their preferred method of pain management and they received more than a thousand comments on marijuana and kratom.

It is highly likely that cannabis companies like Cannabis Global Inc. (OTC: CBGL) will be following the decisions that the CDC makes after receiving the public input the agency has called for.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Cannabis Global (OTC: CBGL), a cannabinoid and hemp-extract, science-forward company developing infusion and delivery technologies, is preparing for two different distribution launches: a new affiliate marketing program that emphasizes its Hemp You Can Feel(TM) alcohol replacement cocktail mixers and coffee products, and a joint venture with RXLeaf, a physician-led medical cannabis website focused on education and information dissemination, which will include CBGL’s new Hemp You Can Feel sweeteners product line. Both launches are slated to kickoff in the next week. “Our corporate emphasis is to utilize our unique intellectual property to bring to the marketplace a unique set of hemp-infused products,” said Cannabis Global CEO Arman Tabatabaei in the press release. “We believe we have accomplished this goal via our Hemp You Can Feel infusion technology, which provides meaningful effect at nearly undetectable levels of cannabinoids. We are now preparing to launch this unique product line on multiple platforms and on our website at www.HempYouCanFeel.com.”

To view the full press release, visit http://cnw.fm/pOFzW

About Cannabis Global Inc.

Cannabis Global, formerly known as MCTC Holdings Inc., is a fully audited and reporting company with the U.S. Securities & Exchange Commission. The company is an emerging force in the area of cannabinoid sciences and highly bioavailable hemp- and cannabis-infusion technologies. The company does not engage in the production, distribution or sales of any controlled substances, including marijuana. CBGL has an actively growing portfolio of intellectual property, having filed six patents in the areas of cannabinoid delivery systems and cannabinoid polymeric nanoparticles. The company markets its consumer products under the Hemp You Can Feel brand name. Cannabis Global launched its Project Varin early in 2020, designed to develop new delivery methods for rare cannabinoid tetrahydrocannabivarin (“THV-C”) and to develop products based on this cannabinoid. For more information about the company, visit www.CannabisGlobalInc.com.

NOTE TO INVESTORS: The latest news and updates relating CBGL are available in the company’s newsroom at http://cnw.fm/CBGL

About HempWire

HempWire (HW) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWire (HW) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWire.com

Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.HempWire.com/Disclaimer

Do you have questions or are you interested in working with HW? Ask our Editor

HempWire (HW)
Denver, Colorado
www.HempWire.com
303.498.7722 Office
Editor@HempWire.net

HempWire is part of the InvestorBrandNetwork.

Are you considering visiting a local marijuana dispensary for the first time? You may think that they don’t differ much from liquor stores, they are both retail establishments that sell a drug after all. Heck, cannabis advocates looking to legalize recreational marijuana said that once legalized, it would be taxed and regulated “in a manner similar to alcohol.” Adults 21 and over would ideally be able to stroll into a cannabis dispensary, grab whatever they need, and leave shortly, as they would in a liquor store. However, cannabis is a unique industry that’s unlike any other, and it differs from alcohol in several ways.

For starters, marijuana dispensaries are a lot more serious about the age limit. While you have to be 21 years old to buy alcohol from a retail establishment, liquor stores can be a little lax with their security. It’s not uncommon to see a young fella rifling through their pockets at the liquor store counter for a moment before sheepishly declaring that they left their ID at home but that they are definitely old enough. Dispensaries, on the other hand, require IDs even before you can walk in and many establishments have security personnel posted at the entrance to make sure customers are old enough.

Additionally, liquor stores are known for their fairly quick service. You can walk in, grab whatever you need, pay, and leave in a couple of minutes. You know what you want, you probably know exactly where in the store it is and you don’t need anyone’s help or guidance on how to use your beverage of choice. In a marijuana dispensary, on the other hand, you will most likely have to talk to a ‘budtender’ before you can make a purchase. A budtender is an in-store expert on everything cannabis, and a cannabis dispensary will probably have a few of them on the floor answering customer questions and offering product recommendations.

A trip to a cannabis dispensary will without a doubt take longer. Liquor stores usually have high customer turnovers, with customers completing their transactions within a matter of minutes. At a marijuana dispensary, there’ll probably be a long line of customers, high demand, and all. After showing your ID, you will have to wait for a budtender to guide you accordingly, especially if it is your first visit. Many budtenders are known to spend as much as 10-20 minutes with new customers just to make sure everything is going alright.

While the dispensary experience may be different, most of the measures are there to protect both the dispensary and the customers. They ensure the dispensaries follow state regulations and that customers have access to all the information they need to make informed decisions when they buy and consume cannabis. This could explain why cannabis companies like Cannabis Global Inc. (OTC: CBGL) go to great lengths to give clients lots of information about what is available.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.